JY
HRMY icon

Jeff Yass’s Harmony Biosciences HRMY Stock Holding History

Jeff Yass’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.2M Buy
87,800
+29,800
+51% +$940K ﹤0.01% 5500
2026
Q1 		$1.62M Sell
58,000
-5,400
-9% -$177K ﹤0.01% 6658
2025
Q4 		$2.37M Sell
63,400
-84,800
-57% -$2.79M ﹤0.01% 5287
2025
Q3 		$4.08M Buy
148,200
+85,100
+135% +$2.93M ﹤0.01% 4433
2025
Q2 		$1.99M Buy
63,100
+34,400
+120% +$1.11M ﹤0.01% 5785
2025
Q1 		$953K Sell
28,700
-400
-1% -$14.3K ﹤0.01% 7379
2024
Q4 		$1M Sell
29,100
-2,300
-7% -$79K ﹤0.01% 6931
2024
Q3 		$1.26M Sell
31,400
-8,400
-21% -$295K ﹤0.01% 6292
2024
Q2 		$1.2M Buy
39,800
+13,000
+49% +$391K ﹤0.01% 6145
2024
Q1 		$900K Buy
26,800
+10,600
+65% +$340K ﹤0.01% 7157
2023
Q4 		$523K Sell
16,200
-47,100
-74% -$1.31M ﹤0.01% 8557
2023
Q3 		$2.07M Buy
63,300
+27,400
+76% +$951K ﹤0.01% 5047
2023
Q2 		$1.26M Buy
35,900
+15,600
+77% +$539K ﹤0.01% 6156
2023
Q1 		$663K Buy
+20,300
New +$924K ﹤0.01% 7866
2022
Q4 		– Sell
-8,900
Closed -$394K – 12943
2022
Q3 		$394K Buy
8,900
+3,000
+51% +$146K ﹤0.01% 9090
2022
Q2 		$288K Buy
5,900
+1,300
+28% +$58.5K ﹤0.01% 9668
2022
Q1 		$224K Buy
+4,600
New +$188K ﹤0.01% 10963

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HRMY Position: Q2 2026 in Review

Jeff Yass increased its Harmony Biosciences (HRMY) stake by 479% in Q2 2026, buying an estimated $3.84M and bringing the position to 147,176 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4476.

Jeff Yass first reported a position in HRMY in Q1 2021 and has held it in 17 quarters since. 325 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jeff Yass held 147,176 shares of Harmony Biosciences worth $5.36M as of Q2 2026.
  • Jeff Yass bought 121,775 Harmony Biosciences shares in Q2 2026, an estimated $3.84M.
  • Harmony Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4476 holding.
  • Jeff Yass first reported a position in Harmony Biosciences in Q1 2021 and has held it in 17 quarters since.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.